Professors David de Kretser, Bryan Hudson and Henry Burger |
The name Hudson was
chosen to recognise the shared history of both MIMR and PHI. The late Professor
Bryan Hudson was the first Professor of Medicine at Monash University and the
Founding Chair of the University’s Department of Medicine. He then became Founding
Director of Prince Henry’s Hospital Medical Research Centre (MRC, subsequently
Prince Henry’s Institute). In this role he established Prince Henry’s Hospital
as the key Monash University academic teaching hospital with the first Monash
MBBS medical cohort of 29 students graduating in 1966.
He also recruited a
number of key medical and scientific staff who were integral to the history of
both PHI and MIMR. These include Professor Henry Burger, Director of MRC/PHI
(1969-1998), Professor David de Kretser, founding Director of the Monash
Institute of Reproduction and Development (subsequently MIMR) and respected
respiratory physician, the late Associate Professor Blair Ritchie, who was
involved in the establishment of what is now The Ritchie Centre. Professor
Hudson was a key driver in the search for ‘inhibin’ bringing together,
Professors Burger and de Kretser, who subsequently led the successful discovery
of this new hormone in 1986.
Other future leaders
who developed under his leadership were Professor David Healy, who completed
his PhD under the supervision of Professor Henry Burger at the MRC and went on
to become the Professor and Chair of Obstetrics and Gynaecology at Monash
University. Professor Peter Fuller, now Associate Director of MIMR-PHI Institute
worked with closely with Bryan Hudson in the Endocrinology clinic at Prince
Henry’s Hospital.
Professor Hudson was
an internationally renowned endocrinologist; serving as the President of the
International Endocrine Society (1980-1984) and becoming President of the Royal
Australasian College of Physicians (1982-1984). A brilliant teacher and
researcher; he was a leader, innovator, visionary and an iconoclast.
The name ‘Hudson
Institute of Medical Research’ was arrived at after a comprehensive process of
consultation. First, responses from the Institute-wide survey were collated and
analysed. The overwhelming consensus was that a new name was needed and that it
should be ‘meaningful’ to the Institute. Several names were put forward by
staff in the survey which were taken to branding consultants, Hello Creative,
who then interviewed Centre Heads for their input. After reviewing all the
options, the feedback from the majority of Centre Heads was that the Institute
should be named after a person – either someone who contributed to the
Institute in some way or who has a good standing in the scientific community. A
review of crucial individuals in the histories of MIMR and PHI showed that the
earliest and most influential seed at the very origins of both Institutes was
Professor Hudson, a world-class medical researcher.
Naming is just the first stage in the branding process. The branding consultants, Hello Creative, will develop the Institute's new logo and 'look', a process which will take approximatey 8 weeks to finalise.
The Institute will retain the name MIMR-PHI Institute until May 2015 when the new name
and brand is ready to be launched externally. At this time, website and all
external communications and promotional items will be changed over to Hudson
Institute.
This will mean that grant applications
prior to May will be under the current Institute name. We will be providing further updates
over the coming weeks. If you have any queries please contact development.office@mimr-phi.org.
No comments:
Post a Comment